Key result
Administration of the granulocyte elastase inhibitor ONO-5046 significantly attenuated the formation of hemorrhagic shock-induced gastric mucosal lesions in rats.
Why the study?
Does ONO-5046 reduce hemorrhagic shock-induced gastric mucosal lesions in a rat model?
RCT
randomized
No
Does ONO-5046 reduce hemorrhagic shock-induced gastric mucosal lesions in a rat model?
Granulocyte elastase plays an important role in the pathogenesis of hemorrhagic shock-induced gastric mucosal lesions, and its inhibition attenuates lesion formation in a rat model.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; hypothesis-generating for elastase inhibition in human shock.
Objective To investigate the mechanism by which activated leukocytes induce gastric mucosal lesions, we examined whether granulocyte elastase is involved in the formation of such lesions in a rat model of hemorrhagic shock. Design Prospective, randomized, controlled study. Setting Research laboratory at a university medical center. Subjects Male Wistar rats, weighing 220 to 280 g. Interventions Animals were subjected to hemorrhagic shock by phlebotomy. ONO-5046, a granulocyte elastase inhibitor (300 mg/kg ip), was administered 30 mins before or after phlebotomy. The effects of antithrombotic substances and tranexamic acid on hemorrhagic shock-induced gastric mucosal lesions also were examined. The effects of granulocyte elastase on the thrombomodulin activity and35 S-glycosaminoglycan content of endothelial cells were examined, using cultured human umbilical vein endothelial cells. Measurements and Main Results Three hours after phlebotomy, linear gastric mucosal erosions were observed. Formation of these lesions, as evaluated by the total linear length, was attenuated significantly by posttreatment as well as pretreatment of animals with ONO-5046. Administration of antithrombin III and an inactive factor Xa derivative, a selective inhibitor of thrombin generation, significantly prevented gastric mucosal lesion formation, while tranexamic acid, an inhibitor of thrombolysis, significantly worsened lesion formation. When incubated with cultured endothelial cells, granulocyte elastase markedly decreased the endothelial thrombomodulin activity and glycosaminoglycan content. These effects of granulocyte elastase were significantly decreased by ONO-5046. Conclusions These observations strongly suggest that granulocyte elastase plays an important role in the pathogenesis of hemorrhagic shock-induced gastric mucosal lesions. Additionally, endothelial cell injury induced by granulocyte elastase may eventually lead to microthrombus formation, which in turn could be an important etiologic factor leading to ischemia in gastric mucosal lesion formation. (Crit Care Med 1996; 24:1041-1046)
No takes yet. Share an insight, caveat, or question.
Kushimoto et al. (1996) conducted an RCT in hemorrhagic shock-induced gastric mucosal lesions. ONO-5046 vs. control was evaluated on Formation of gastric mucosal lesions (total linear length). Administration of the granulocyte elastase inhibitor ONO-5046 significantly attenuated the formation of hemorrhagic shock-induced gastric mucosal lesions in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: